Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06671457, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Zhen Wang
- Trial code
- NCT06671457
- Record updated
- 21 August 2025
- Original description
This study is designed to evaluate the efficacy and to explore the best individualized stimulus paradigm of transcranial Electrical Stimulation for insomnia patients.Read full original descriptionShow less
This study is designed to evaluate the efficacy and to explore the best individualized stimulus paradigm of transcranial Electrical Stimulation for insomnia patients.
Inclusion: Age between 18 and 65 years; Meets the diagnostic criteria for insomnia disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); Has not taken psychiatric medications in the 8 weeks prior to enrollment or has been on stable psychiatric medication for 8 weeks (excluding benzodiazepines); Insomnia severity as indicated by an ISI score > 10; Minimum education level of junior high school or above.
Exclusion: Currently using benzodiazepines as sleep aids; Previous treatment with ECT, rTMS, tES, or cognitive behavioral therapy for insomnia disorder; Past or current diagnosis of disorders other than insomnia disorder, anxiety disorder, or depressive disorder according to DSM-5; Patients with obstructive sleep apnea syndrome; Severe physical illnesses or any condition that may induce seizures or intracranial hypertension, including cardiovascular or respiratory diseases; History of neurological disorders (e.g., epilepsy, cerebrovascular accidents) or history of brain injury or brain surgery; Presence of implantable medical devices such as intracranial stents, cardiac pacemakers, coronary stents, or cochlear implants; Moderate to severe anxiety or depression (HAMD-17 score > 16 or HAMA score > 24); Severe negative thoughts or high suicide risk; Pregnant or planning to conceive in the near future.